WLF DEPOSITION OF FDA COMMISSIONER KESSLER IS JUSTIFIED BY "DIRECT" INVOLVEMENT WITH CME POLICY, FOUNDATION ARGUES; COURT RULING ON ISSUE EXPECTED IN MAY
This article was originally published in The Gray Sheet
Executive SummaryFDA Commissioner David Kessler's "direct, active role" in formulating the agency's draft policy on industry-sponsored continuing medical education makes him eligible for deposition, the Washington Legal Foundation says in a motion recently filed in the U.S. District Court for the District of Columbia as part of its suit against the policy. The motion says that "given Dr. Kessler's intimate personal involvement in the issues giving rise to this suit, WLF is entitled to question him regarding his knowledge of those issues."
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.